Rumours that the Blackmores’ board – and its largest individual shareholder Marcus Blackmore – were open to a takeover have bubbled away for at least 18 months.
Kirin’s is expected to double down on Blackmores’ R&D capabilities and new product development in the wake of its $1.2bn deal, according to exclusive insights from the Japanese giant and industry experts.
Kirin Holdings has agreed to buy Australian vitamin-maker Blackmores for 1.88 billion Australian dollars ($1.24 billion, ¥165.9 billion) in cash, as part o